FdaApplication
ANDA 204626
Identifiers
- fda_app_no: ANDA204626
Properties
| Property | Value |
|---|---|
| applicant_name | IPCA LABORATORIES LTD |
| application_type | ANDA |
| approval_date | 2024-05-06 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| LEVOCETIRIZINE DIHYDROCHLORIDE | LEVOCETIRIZINE DIHYDROCHLORIDE | 5MG | TABLET;ORAL |
1 product